NCT01876381
A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2013
Completion: Feb 28, 2014